Did These 5 Stocks Miss or Beat Analyst Expectations?

ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) had a loss and missed Wall Street’s expectations, BUT beat the revenue expectation. Adjusted Earnings Per Share decreased to $-0.48 in the quarter versus EPS of $-0.19 in the year-earlier quarter. Revenue Was the same at $200,000 as the year-earlier quarter.

ZIOPHARM Oncology, Inc. reported adjusted EPS loss of $0.48 per share. By that measure, the company missed the mean analyst estimate of $-0.29. It beat the average revenue estimate of $0.

The stock market is at 5-year highs! Discover the best stocks to buy in today’s market. CLICK HERE for Your Stock Investor Cheat Sheet NOW!

ZIOP

Omeros Corporation (NASDAQ:OMER) had a loss and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share increased to $-0.3 in the quarter versus EPS of $-0.46 in the year-earlier quarter. Revenue Rose 38.6% to $1.58 million from the year-earlier quarter.

Omeros Corporation reported adjusted EPS loss of $0.3 per share. By that measure, the company beat the mean analyst estimate of $-0.34. It beat the average revenue estimate of $1.5 million.

The stock market is at 5-year highs! Discover the best stocks to buy in today’s market. CLICK HERE for Your Stock Investor Cheat Sheet NOW!

OMER

Cross Country Healthcare, Inc. (NASDAQ:CCRN) had a loss and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share decreased to $-0.31 in the quarter versus EPS of $0.04 in the year-earlier quarter. Revenue Decreased 10.42% to $111.73 million from the year-earlier quarter.

Cross Country Healthcare, Inc. reported adjusted EPS loss of $0.31 per share. By that measure, the company missed the mean analyst estimate of $-0.01. It missed the average revenue estimate of $126.52 million.

The stock market is at 5-year highs! Discover the best stocks to buy in today’s market. CLICK HERE for Your Stock Investor Cheat Sheet NOW!

CCRN

3SBio Inc. (NASDAQ:SSRX) delivered a profit and missed Wall Street’s expectations, BUT beat the revenue expectation. Adjusted Earnings Per Share decreased 25% to $0.12 in the quarter versus EPS of $0.16 in the year-earlier quarter. Revenue Rose 12.01% to $26.3 million from the year-earlier quarter.

3SBio Inc. reported adjusted EPS income of $0.12 per share. By that measure, the company missed the mean analyst estimate of $0.14. It beat the average revenue estimate of $25.64 million.

The stock market is at 5-year highs! Discover the best stocks to buy in today’s market. CLICK HERE for Your Stock Investor Cheat Sheet NOW!

SSRX

Savient Pharmaceuticals, Inc. (NASDAQ:SVNT) had a loss and beat Wall Street’s expectations, BUT came up short on beating the revenue expectation. Adjusted Earnings Per Share increased to $-0.39 in the quarter versus EPS of $-0.44 in the year-earlier quarter. Revenue Rose 32.08% to $4.9 million from the year-earlier quarter.

Savient Pharmaceuticals, Inc. reported adjusted EPS loss of $0.39 per share. By that measure, the company beat the mean analyst estimate of $-0.44. It missed the average revenue estimate of $6.18 million.

The stock market is at 5-year highs! Discover the best stocks to buy in today’s market. CLICK HERE for Your Stock Investor Cheat Sheet NOW!

SVNT
Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.